Point Biopharma
POINT is a pharmaceutical firm that researches, develops, and commercializes radioligand therapies for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Point Biopharma Information
Geographic Data
Address: 22 St. Clair Avenue East
City: Toronto
State: ontario
Zip: M4T 2S3
Country: CA
Financial Info
Stage:
post ipo equity
Raised Last:
$165M
Raised Total:$155M
Social
Metrics
2,630,952Website Global Rank
6,705Website Monthly Traffic
Twitter Followers
Description
POINT is a pharmaceutical firm that researches, develops, and commercializes radioligand therapies for the treatment of cancer.
Contact Phone:
+16478122417
Contact Email:
Point Biopharma went public on 7/1/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/1/2021
IPO Valuation:
$924M
Ticker Symbol:
PNT
Amount Raised:
$287M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
